Sutro

May 16, 2019

Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress

Jan 29, 2019

Sutro Biopharma Expands Leadership Team with Appointment of Vice President of Chemistry

Jan 03, 2019

Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference

Dec 19, 2018

Sutro Achieves $10 Million Milestone Payment from Celgene

Nov 14, 2018

Sutro Biopharma Reports Third Quarter 2018 Financial Results

Sep 12, 2018

Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief

Jul 26, 2018

Sutro Biopharma Announces $85.4 Million Series E Round

Jul 24, 2018

Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders

Apr 26, 2018

Sutro Initiates First Clinical Trial of CD74-Targeting ADC for Lymphoma & Multiple Myeloma Treatment; The First of a New Generation of Precisely Engineered ADCs

Apr 16, 2018

Sutro ADC Effectively Targets Folate Receptor Alpha in Ovarian Cancer Preclinical Research

Oct 11, 2017

Sutro Marks Two Drug Development Milestones

Aug 10, 2017

Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs